Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24773
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKatopodis, K. P.en
dc.contributor.authorDounousi, E.en
dc.contributor.authorChalla, A.en
dc.contributor.authorPappas, K.en
dc.contributor.authorKalaitzidis, R.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T19:43:31Z-
dc.date.available2015-11-24T19:43:31Z-
dc.identifier.issn1538-943X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24773-
dc.rightsDefault Licence-
dc.subjectBlood Pressure/physiologyen
dc.subjectBody Weight/physiologyen
dc.subjectErythropoietin/therapeutic useen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectKidney Failure, Chronic/complications/*therapyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPilot Projectsen
dc.subjectRecombinant Proteinsen
dc.subjectRenal Dialysis/*methodsen
dc.subjectStroke Volume/physiologyen
dc.subjectUremia/etiologyen
dc.subjectVentricular Function, Left/physiologyen
dc.titleSwitch from conventional to every other day hemodialysis: a comparison pilot studyen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1097/MAT.0b013e318191f153-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19092650-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractFluid and solute fluctuations during the week are the main drawbacks of conventional hemodialysis (cHD) in patients' outcomes. The aim of our study was to evaluate the influence of every other day hemodialysis (eodHD) on clinical and laboratory parameters and to compare to that of cHD. Eighteen patients on cHD were included in the study. Nine patients (group I) were randomly switched to eodHD, while the rest (group II) remained on their regular cHD. By the end of the study (12 months) we observed a reduction in body weight followed by a parallel reduction in predialysis mean blood pressure by 7 mm Hg in group I (p<0.05) and the number of antihypertensives. Moreover, a reduction in left ventricular mass and an increment of ejection fraction was observed in group I. Hemoglobin levels remained stable in both groups, but erythropoietin dose was reduced in eodHD group. Dialysis delivered dose (dpKt/V) was higher and urea rebound phenomenon was less in group I. Finally, an improvement in uremia related and postdialysis symptoms was observed in the same group of patients. Our results showed that eodHD improved patients' clinical and biochemical status and therefore might have advantages in patients' outcomes compared with cHD.en
heal.journalNameASAIO Jen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons